AstraZeneca

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AstraZeneca and other ETFs, options, and stocks.

About AZN

AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company’s history roots back to the year 1913 when Astra business was formed. 

CEO
Pascal Soriot
CEOPascal Soriot
Employees
94,300
Employees94,300
Headquarters
Cambridge, Cambridgeshire
HeadquartersCambridge, Cambridgeshire
Founded
1913
Founded1913
Employees
94,300
Employees94,300

AZN Key Statistics

Market cap
251.39B
Market cap251.39B
Price-Earnings ratio
30.38
Price-Earnings ratio30.38
Dividend yield
1.88%
Dividend yield1.88%
Average volume
3.48M
Average volume3.48M
High today
$81.30
High today$81.30
Low today
$80.74
Low today$80.74
Open price
$81.03
Open price$81.03
Volume
610.67K
Volume610.67K
52 Week high
$83.43
52 Week high$83.43
52 Week low
$61.24
52 Week low$61.24

AZN News

Benzinga 21h
AstraZeneca Lung Cancer Combo Extends Patient Survival By Years In Key Study

On Sunday, AstraZeneca Plc (AZN) released results from the final overall survival (OS) analysis of the FLAURA2 Phase 3 trial in previously untreated patients wi...

AstraZeneca Lung Cancer Combo Extends Patient Survival By Years In Key Study
TipRanks 2d
AstraZeneca’s PROVIDENCE Study: Real-world Insights into Trastuzumab Deruxtecan for Metastatic Breast Cancer

AstraZeneca ((AZN)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unloc...

TipRanks 2d
AstraZeneca’s Promising Phase II Study on AZD0901 for Advanced Solid Tumors

AstraZeneca ((AZN)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unloc...

Analyst ratings

83%

of 30 ratings
Buy
83.3%
Hold
16.7%
Sell
0%

More AZN News

TipRanks 2d
AstraZeneca’s Latest Phase 4 Study: A Boost for HER2-Positive Breast Cancer Treatment?

AstraZeneca ((AZN)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unloc...

TipRanks 2d
AstraZeneca’s Tezepelumab Study: A Potential Game-Changer for COPD Treatment

AstraZeneca ((AZN)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unloc...

TipRanks 2d
AstraZeneca’s ALXN1920 Study: A New Hope for Kidney Disease Treatment?

AstraZeneca ((AZN)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock...

TipRanks 2d
AstraZeneca’s Promising Phase II Study for Liver Cancer Treatment

AstraZeneca ((AZN)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unloc...

TipRanks 2d
AstraZeneca’s Observational Study on SLE in Kazakhstan: Key Insights for Investors

AstraZeneca ((AZN)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unloc...

TipRanks 2d
AstraZeneca’s DAISY Study: A New Hope for Systemic Sclerosis Treatment

AstraZeneca ((AZN)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock...

TipRanks 2d
AstraZeneca’s Phase I Trial of AZD1613: A Potential Game-Changer?

AstraZeneca ((AZN)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unloc...

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.